Retatrutide, developed by Soma Pharmaceuticals , is attracting increasing attention as a potential method for weight management . This innovative drug integrates the properties of a GLP-1 receptor stimulant and a GIP receptor stimulant, designed to simply promote weight loss but also improve rela